Cefovista-S Injection

CEFOVISTA-S is a broad-spectrum antibacterial injection from Solvista Healthcare, formulated with Ceftriaxone and Sulbactam. It is designed to effectively treat a wide range of bacterial infections and is administered through Intramuscular (I.M.) or Intravenous (I.V.) routes.

Product Identification & Specifications

• Brand Name: Cefovista-S Injection
• Manufacturer/Marketer: Solvista Healthcare
• Active Ingredients: Ceftriaxone & Sulbactam for Injection I.P. (Indian Pharmacopoeia)
• Strength: 1.5g (1.5gm) per vial
• Dosage Form: Sterile powder for injection, accompanied by a sterile water ampoule for reconstitution.
• Route of Administration: Intramuscular (I.M.) or Intravenous (I.V.) use only.
• Key Certifications: * WHO-GMP Certified (World Health Organization – Good Manufacturing Practices)
  • ISO Certified
  • Quality Assured

Active Ingredient Breakdown

1. Ceftriaxone: This third-generation cephalosporin antibiotic exhibits broad-spectrum activity against both Gram-negative and Gram-positive bacteria. In terms of its mechanism, it works by inhibiting bacterial cell wall synthesis, which ultimately causes bacterial cell death (bactericidal action).
2. Sulbactam: This compound acts as a powerful beta-lactamase inhibitor. Indeed, many bacteria produce enzymes called beta-lactamases, which destroy beta-lactam antibiotics like Ceftriaxone and render them ineffective. However, Sulbactam irreversibly binds to and inactivates these enzymes. Consequently, it protects Ceftriaxone from degradation and restores its powerful antibacterial efficacy.

Key Therapeutic Indications

According to clinical documentation, physicians prescribe Cefovista-S to manage moderate-to-severe bacterial infections. In particular, these infections include:

• Respiratory Tract Infections: Such as community-acquired pneumonia, acute bronchitis, and bronchiectasis.
• Urinary Tract Infections (UTIs): Including complicated UTIs and pyelonephritis.
• Skin and Soft Tissue Infections: Such as cellulitis, wound infections, and abscesses.
• Other Systemic Infections: Including intra-abdominal infections, joint/bone infections, and bacterial meningitis.

Frequently Asked Questions (FAQs)

Q1: What is Cefovista-S Injection used for?

Answer: Primarily, doctors prescribe Cefovista-S, a prescription antibiotic injection, to treat various moderate-to-severe bacterial infections. For instance, common indications include respiratory tract infections (like pneumonia), urinary tract infections (UTIs), skin and soft tissue infections, bone and joint infections, and other severe bacterial conditions. Furthermore, patients should note that Cefovista-S only targets bacterial infections, and it will not work for viral infections like the common cold or flu.

Q2: Why does Cefovista-S contain two active ingredients (Ceftriaxone & Sulbactam)?

Answer: Essentially, researchers formulated this combination to overcome bacterial resistance. Ceftriaxone serves as the primary antibiotic that destroys bacteria. However, some advanced bacteria produce defensive enzymes called “beta-lactamases” that destroy Ceftriaxone before it can work. To counter this, Sulbactam acts as a beta-lactamase inhibitor that blocks these enzymes. As a result, Ceftriaxone can safely do its job and eradicate the infection effectively.

Q3: How is Cefovista-S administered, and can I administer it myself?

Answer: Generally, clinicians administer Cefovista-S either directly into a vein (Intravenous/I.V.) or deep into a muscle (Intramuscular/I.M.). In addition, a qualified healthcare professional (doctor, nurse, or clinical technician) must reconstitute the drug with sterile water and perform the subsequent injection. Consequently, medical experts strongly discourage self-administration, as this prevents serious complications such as infection, incorrect dosing, or tissue damage.

Q4: What are the certifications and quality standards associated with Cefovista-S?

Answer: To ensure safety, Solvista Healthcare produces Cefovista-S in state-of-the-art facilities that adhere to global quality standards. Specifically, the product carries WHO-GMP certification (indicating strict compliance with World Health Organization Good Manufacturing Practices) and ISO certification. Consequently, these certifications guarantee that the drug meets rigorous benchmarks for high purity, efficacy, and clinical safety.

Q5: Are there any side effects or precautions I should be aware of?

Answer: Like all antibiotics, Cefovista-S can sometimes cause side effects. For example, common reactions include localized pain or swelling at the injection site, mild diarrhea, nausea, or a temporary rash. In addition, serious allergic reactions (anaphylaxis) remain rare but possible, particularly in patients with a history of penicillin or cephalosporin allergies. Therefore, you should always inform your doctor of your complete allergy history, kidney/liver conditions, and any concurrent medications before starting treatment.